Asia Pacific (India, China, Australia, South Korea & Others) Insulin Market (Rapid Acting, Short Acting, Pre-Mixed, Long Acting, Type I & II Diabetes, Analogs & Recombinant Insulin) Analysis And Segment Forecasts To 2020
The Asia Pacific market for Insulin is expected to reach USD 15.04 billion by 2020. Growing regional prevalence of diabetes, increasing market penetration rates of modern insulin products in emerging markets such as India and China is expected to drive market growth during the forecast period. Furthermore, patent expiration of key products such as Lantus is expected to trigger the manufacturing of biosimilars from local manufacturers such as Biocon.
Long acting analog dominated the overall market in terms of revenue share in 2013, with revenue estimated at USD 2,051.9 million. High prices coupled with relatively higher efficacies exhibited by these products account for its large share. Rapid acting analogs followed the long acting segment in 2013 accounting for a revenue share of over 25.0% on account of their high market penetration rates in developed markets such as Australia and Japan.
Further key findings from the study suggest:
The analogs source segment accounted for the largest revenue share in 2013 was valued at USD 3,441.7 million. Growing demand for analogs in emerging markets with high unmet medical needs such as China and India is one of the major factors attributing to its large share.
Japan, on behalf of its sophisticated healthcare infrastructure, high patient awareness and disposable income levels dominated the market in 2013 with a revenue share of over 38.0%.
China on the other hand is expected to register the highest CAGR of 21.1% during the forecast period owing to the growing prevalence of type I and type diabetes and the expected decline in insulin prices as a result of continued initiatives to improve healthcare access.
The Asia Pacific insulin market is oligopolistic in nature and is dominated by three key players including Novo Nordisk, Eli Lilly and Sanofi Aventis.
For the purpose of this study, Grand View Research has segmented the Asia Pacific Insulin market on the basis of product, application, source and region:
Long acting analog dominated the overall market in terms of revenue share in 2013, with revenue estimated at USD 2,051.9 million. High prices coupled with relatively higher efficacies exhibited by these products account for its large share. Rapid acting analogs followed the long acting segment in 2013 accounting for a revenue share of over 25.0% on account of their high market penetration rates in developed markets such as Australia and Japan.
Further key findings from the study suggest:
The analogs source segment accounted for the largest revenue share in 2013 was valued at USD 3,441.7 million. Growing demand for analogs in emerging markets with high unmet medical needs such as China and India is one of the major factors attributing to its large share.
Japan, on behalf of its sophisticated healthcare infrastructure, high patient awareness and disposable income levels dominated the market in 2013 with a revenue share of over 38.0%.
China on the other hand is expected to register the highest CAGR of 21.1% during the forecast period owing to the growing prevalence of type I and type diabetes and the expected decline in insulin prices as a result of continued initiatives to improve healthcare access.
The Asia Pacific insulin market is oligopolistic in nature and is dominated by three key players including Novo Nordisk, Eli Lilly and Sanofi Aventis.
For the purpose of this study, Grand View Research has segmented the Asia Pacific Insulin market on the basis of product, application, source and region:
- Insulin Product Outlook
- Rapid acting
- Long acting
- Premixed
- Premixed analog
- Short acting
- Intermediate acting
- Insulin Application Outlook
- Type I and Other Diabetes
- Type II Diabetes
- Insulin Source Outlook
- Human Recombinant
- Analogs
- Insulin Regional Outlook
- India
- China
- Australia
- New Zealand
- South Korea
- Taiwan
- Philippines
- Vietnam
- Indonesia
- Japan
- Malaysia
- Thailand
- Rest of Asia Pacific
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Asia Pacific Insulin – Industry Summary and Critical Success Factors (CSFs)
CHAPTER 2. ASIA PACIFIC INSULIN INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Asia Pacific Insulin Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Asia Pacific Insulin - Company Market Share Analysis
2.7. Asia Pacific Insulin Market PESTEL Analysis, 2012
2.8. Asia Pacific Insulin – Pipeline Overview
CHAPTER 3. ASIA PACIFIC INSULIN PRODUCT OUTLOOK, VOLUME (NUMBER OF UNITS) AND VALUE (USD MILLION) ESTIMATES AND FORECASTS, 2012 - 2020
3.1. Rapid Acting Analog
3.1.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.2. Short Acting Insulin
3.2.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.3. Intermediate Acting Insulin
3.3.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.4. Long Acting Analog
3.4.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.5. Pre-Mixed
3.5.1.Pre-Mixed Insulin Market Estimates and Forecasts
3.5.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.5.2.Pre-Mixed Analog Market Estimates and Forecasts
3.5.2.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
CHAPTER 4. ASIA PACIFIC INSULIN SEGMENT (ON THE BASIS OF SOURCE) OUTLOOK, VOLUME (NUMBER OF UNITS) AND VALUE (USD MILLION) ESTIMATES AND FORECASTS, 2012 - 2020
4.1. Insulin Analogs
4.1.1.Insulin Analogs Market Estimates and Forecasts
4.2. Human Recombinant Insulin
4.2.1. Human Recombinant Insulin Market Estimates and Forecasts
CHAPTER 5. ASIA PACIFIC INSULIN APPLICATION OUTLOOK (USD MILLION) ESTIMATES AND FORECASTS, 2012 - 2020
5.1. Type I and Other Diabetes
5.1.1. Type I and Other Diabetes Market Estimates and Forecasts
5.2. Type II Diabetes
5.2.1. II Diabetes Market Estimates and Forecasts
CHAPTER 6. INSULIN REGIONAL OUTLOOK, VOLUME (NUMBER OF UNITS) AND VALUE (USD MILLION) ESTIMATES AND FORECASTS, 2012 - 2020
6.1. India
6.1.1. India Insulin Market, by Products
6.1.2. India Insulin Market, by Applications (only revenue)
6.1.3. India Insulin Market, by Source
6.2. China
6.2.1. China Insulin Market, by Products
6.2.2. China Insulin Market, by Applications (only revenue)
6.2.3. China Insulin Market, by Source
6.3. Australia
6.3.1. Australia Insulin Market, by Products
6.3.2. Australia Insulin Market, by Applications (only revenue)
6.3.3. Australia Insulin Market, by Source
6.4. New Zealand
6.4.1. New Zealand Insulin Market, by Products
6.4.2. New Zealand Insulin Market, by Applications (only revenue)
6.4.3. New Zealand Insulin Market, by Source
6.5. South Korea
6.5.1. South Korea Insulin Market, by Products
6.5.2. South Korea Insulin Market, by Applications (only revenue)
6.5.3. South Korea Insulin Market, by Source
6.6. Taiwan
6.6.1. Taiwan Insulin Market, by Products
6.6.2. Taiwan Insulin Market, by Applications (only revenue)
6.6.3. Taiwan Insulin Market, by Source
6.7. Philippines
6.7.1. Philippines Insulin Market, by Products
6.7.2. Philippines Insulin Market, by Applications (only revenue)
6.7.3. Philippines Insulin Market, by Source
6.8. Vietnam
6.8.1. Vietnam Insulin Market, by Products
6.8.2. Vietnam Insulin Market, by Applications (only revenue)
6.8.3. Vietnam Insulin Market, by Source
6.9. Indonesia
6.9.1. Indonesia Insulin Market, by Products
6.9.2. Indonesia Insulin Market, by Applications (only revenue)
6.9.3. Indonesia Insulin Market, by Source
6.10. Japan
6.10.1. Japan Insulin Market, by Products
6.10.2. Japan Insulin Market, by Applications (only revenue)
6.10.3. Japan Insulin Market, by Source
6.11. Malaysia
6.11.1. Malaysia Insulin Market, by Products
6.11.2. Malaysia Insulin Market, by Applications (only revenue)
6.11.3. Malaysia Insulin Market, by Source
6.12. Thailand
6.12.1. Thailand Insulin Market, by Products
6.12.2. Thailand Insulin Market, by Applications (only revenue)
6.12.3. Thailand Insulin Market, by Source
6.13. Rest of Asia Pacific
Companies analyzed in competitive landscape
Novo Nordisk
Sanofi
Eli Lilly
Bristol-Myers Squibb
Novartis
Takeda Pharmaceuticals
Boehringer Ingelheim
Biocon
Dongbao Enterprise Group Co., Ltd.
Merck KGaA
Oramed Pharmaceuticals Inc.
Halozyme Therapeutics
Wanbang Biopharma
Xinbai Pharmaceutical
Gan & Lee Pharmaceutical
1.1. Asia Pacific Insulin – Industry Summary and Critical Success Factors (CSFs)
CHAPTER 2. ASIA PACIFIC INSULIN INDUSTRY OUTLOOK
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Asia Pacific Insulin Market Dynamics
2.3.1. Market Driver Analysis
2.3.2. Market Restraint Analysis
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Asia Pacific Insulin - Company Market Share Analysis
2.7. Asia Pacific Insulin Market PESTEL Analysis, 2012
2.8. Asia Pacific Insulin – Pipeline Overview
CHAPTER 3. ASIA PACIFIC INSULIN PRODUCT OUTLOOK, VOLUME (NUMBER OF UNITS) AND VALUE (USD MILLION) ESTIMATES AND FORECASTS, 2012 - 2020
3.1. Rapid Acting Analog
3.1.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.2. Short Acting Insulin
3.2.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.3. Intermediate Acting Insulin
3.3.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.4. Long Acting Analog
3.4.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.5. Pre-Mixed
3.5.1.Pre-Mixed Insulin Market Estimates and Forecasts
3.5.1.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
3.5.2.Pre-Mixed Analog Market Estimates and Forecasts
3.5.2.1. Pricing Analysis (Average Selling Price in USD), 2012 – 2020
CHAPTER 4. ASIA PACIFIC INSULIN SEGMENT (ON THE BASIS OF SOURCE) OUTLOOK, VOLUME (NUMBER OF UNITS) AND VALUE (USD MILLION) ESTIMATES AND FORECASTS, 2012 - 2020
4.1. Insulin Analogs
4.1.1.Insulin Analogs Market Estimates and Forecasts
4.2. Human Recombinant Insulin
4.2.1. Human Recombinant Insulin Market Estimates and Forecasts
CHAPTER 5. ASIA PACIFIC INSULIN APPLICATION OUTLOOK (USD MILLION) ESTIMATES AND FORECASTS, 2012 - 2020
5.1. Type I and Other Diabetes
5.1.1. Type I and Other Diabetes Market Estimates and Forecasts
5.2. Type II Diabetes
5.2.1. II Diabetes Market Estimates and Forecasts
CHAPTER 6. INSULIN REGIONAL OUTLOOK, VOLUME (NUMBER OF UNITS) AND VALUE (USD MILLION) ESTIMATES AND FORECASTS, 2012 - 2020
6.1. India
6.1.1. India Insulin Market, by Products
6.1.2. India Insulin Market, by Applications (only revenue)
6.1.3. India Insulin Market, by Source
6.2. China
6.2.1. China Insulin Market, by Products
6.2.2. China Insulin Market, by Applications (only revenue)
6.2.3. China Insulin Market, by Source
6.3. Australia
6.3.1. Australia Insulin Market, by Products
6.3.2. Australia Insulin Market, by Applications (only revenue)
6.3.3. Australia Insulin Market, by Source
6.4. New Zealand
6.4.1. New Zealand Insulin Market, by Products
6.4.2. New Zealand Insulin Market, by Applications (only revenue)
6.4.3. New Zealand Insulin Market, by Source
6.5. South Korea
6.5.1. South Korea Insulin Market, by Products
6.5.2. South Korea Insulin Market, by Applications (only revenue)
6.5.3. South Korea Insulin Market, by Source
6.6. Taiwan
6.6.1. Taiwan Insulin Market, by Products
6.6.2. Taiwan Insulin Market, by Applications (only revenue)
6.6.3. Taiwan Insulin Market, by Source
6.7. Philippines
6.7.1. Philippines Insulin Market, by Products
6.7.2. Philippines Insulin Market, by Applications (only revenue)
6.7.3. Philippines Insulin Market, by Source
6.8. Vietnam
6.8.1. Vietnam Insulin Market, by Products
6.8.2. Vietnam Insulin Market, by Applications (only revenue)
6.8.3. Vietnam Insulin Market, by Source
6.9. Indonesia
6.9.1. Indonesia Insulin Market, by Products
6.9.2. Indonesia Insulin Market, by Applications (only revenue)
6.9.3. Indonesia Insulin Market, by Source
6.10. Japan
6.10.1. Japan Insulin Market, by Products
6.10.2. Japan Insulin Market, by Applications (only revenue)
6.10.3. Japan Insulin Market, by Source
6.11. Malaysia
6.11.1. Malaysia Insulin Market, by Products
6.11.2. Malaysia Insulin Market, by Applications (only revenue)
6.11.3. Malaysia Insulin Market, by Source
6.12. Thailand
6.12.1. Thailand Insulin Market, by Products
6.12.2. Thailand Insulin Market, by Applications (only revenue)
6.12.3. Thailand Insulin Market, by Source
6.13. Rest of Asia Pacific
Companies analyzed in competitive landscape
Novo Nordisk
Sanofi
Eli Lilly
Bristol-Myers Squibb
Novartis
Takeda Pharmaceuticals
Boehringer Ingelheim
Biocon
Dongbao Enterprise Group Co., Ltd.
Merck KGaA
Oramed Pharmaceuticals Inc.
Halozyme Therapeutics
Wanbang Biopharma
Xinbai Pharmaceutical
Gan & Lee Pharmaceutical
LIST OF TABLES
Asia Pacific Insulin – Industry summary & Critical Success Factors (CSFs)
Asia Pacific Insulin Market, by Countries, 2012 – 2020 (USD Million)
Asia Pacific Insulin Market, by Products, 2012 – 2020 (USD Million)
Asia Pacific Insulin Market, by Products, 2012 – 2020 (‘000 Units)
Asia Pacific Insulin Market, by Applications, 2012 – 2020 (USD Million)
Asia Pacific Insulin Market, by Source Types, 2012 – 2020 (USD Million)
Asia Pacific Insulin Market, by Source Types, 2012 – 2020 (‘000 Units)
India Insulin Market, by Products, 2012 – 2020 (USD Million)
India Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
India Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
India Insulin Market, by Product Types, 2012 - 2020 ('000 units)
India Insulin Market, by Source Types, 2012 - 2020 (USD million)
India Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
India Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
China Insulin Market, by Products, 2012 – 2020 (USD Million)
China Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
China Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
China Insulin Market, by Product Types, 2012 - 2020 ('000 units)
China Insulin Market, by Source Types, 2012 - 2020 (USD million)
China Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
China Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Japan Insulin Market, by Products, 2012 – 2020 (USD Million)
Japan Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Japan Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Japan Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Japan Insulin Market, by Source Types, 2012 - 2020 (USD million)
Japan Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Japan Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
South Korea Insulin Market, by Products, 2012 – 2020 (USD Million)
South Korea Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
South Korea Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
South Korea Insulin Market, by Product Types, 2012 - 2020 ('000 units)
South Korea Insulin Market, by Source Types, 2012 - 2020 (USD million)
South Korea Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
South Korea Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Thailand Insulin Market, by Products, 2012 – 2020 (USD Million)
Thailand Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Thailand Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Thailand Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Thailand Insulin Market, by Source Types, 2012 - 2020 (USD million)
Thailand Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Thailand Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Malaysia Insulin Market, by Products, 2012 – 2020 (USD Million)
Malaysia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Malaysia Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Malaysia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Malaysia Insulin Market, by Source Types, 2012 - 2020 (USD million)
Malaysia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Malaysia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Vietnam Insulin Market, by Products, 2012 – 2020 (USD Million)
Vietnam Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Vietnam Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Vietnam Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Vietnam Insulin Market, by Source Types, 2012 - 2020 (USD million)
Vietnam Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Vietnam Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Australia Insulin Market, by Products, 2012 – 2020 (USD Million)
Australia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Australia Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Australia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Australia Insulin Market, by Source Types, 2012 - 2020 (USD million)
Australia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Australia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
New Zealand Insulin Market, by Products, 2012 – 2020 (USD Million)
New Zealand Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
New Zealand Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
New Zealand Insulin Market, by Product Types, 2012 - 2020 ('000 units)
New Zealand Insulin Market, by Source Types, 2012 - 2020 (USD million)
New Zealand Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
New Zealand Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Indonesia Insulin Market, by Products, 2012 – 2020 (USD Million)
Indonesia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Indonesia Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Indonesia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Indonesia Insulin Market, by Source Types, 2012 - 2020 (USD million)
Indonesia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Indonesia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Philippines Insulin Market, by Products, 2012 – 2020 (USD Million)
Philippines Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Philippines Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Philippines Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Philippines Insulin Market, by Source Types, 2012 - 2020 (USD million)
Philippines Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Philippines Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Taiwan Insulin Market, by Products, 2012 – 2020 (USD Million)
Taiwan Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Taiwan Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Taiwan Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Taiwan Insulin Market, by Source Types, 2012 - 2020 (USD million)
Taiwan Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Taiwan Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Asia Pacific Insulin – Industry summary & Critical Success Factors (CSFs)
Asia Pacific Insulin Market, by Countries, 2012 – 2020 (USD Million)
Asia Pacific Insulin Market, by Products, 2012 – 2020 (USD Million)
Asia Pacific Insulin Market, by Products, 2012 – 2020 (‘000 Units)
Asia Pacific Insulin Market, by Applications, 2012 – 2020 (USD Million)
Asia Pacific Insulin Market, by Source Types, 2012 – 2020 (USD Million)
Asia Pacific Insulin Market, by Source Types, 2012 – 2020 (‘000 Units)
India Insulin Market, by Products, 2012 – 2020 (USD Million)
India Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
India Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
India Insulin Market, by Product Types, 2012 - 2020 ('000 units)
India Insulin Market, by Source Types, 2012 - 2020 (USD million)
India Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
India Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
China Insulin Market, by Products, 2012 – 2020 (USD Million)
China Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
China Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
China Insulin Market, by Product Types, 2012 - 2020 ('000 units)
China Insulin Market, by Source Types, 2012 - 2020 (USD million)
China Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
China Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Japan Insulin Market, by Products, 2012 – 2020 (USD Million)
Japan Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Japan Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Japan Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Japan Insulin Market, by Source Types, 2012 - 2020 (USD million)
Japan Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Japan Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
South Korea Insulin Market, by Products, 2012 – 2020 (USD Million)
South Korea Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
South Korea Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
South Korea Insulin Market, by Product Types, 2012 - 2020 ('000 units)
South Korea Insulin Market, by Source Types, 2012 - 2020 (USD million)
South Korea Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
South Korea Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Thailand Insulin Market, by Products, 2012 – 2020 (USD Million)
Thailand Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Thailand Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Thailand Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Thailand Insulin Market, by Source Types, 2012 - 2020 (USD million)
Thailand Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Thailand Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Malaysia Insulin Market, by Products, 2012 – 2020 (USD Million)
Malaysia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Malaysia Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Malaysia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Malaysia Insulin Market, by Source Types, 2012 - 2020 (USD million)
Malaysia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Malaysia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Vietnam Insulin Market, by Products, 2012 – 2020 (USD Million)
Vietnam Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Vietnam Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Vietnam Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Vietnam Insulin Market, by Source Types, 2012 - 2020 (USD million)
Vietnam Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Vietnam Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Australia Insulin Market, by Products, 2012 – 2020 (USD Million)
Australia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Australia Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Australia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Australia Insulin Market, by Source Types, 2012 - 2020 (USD million)
Australia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Australia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
New Zealand Insulin Market, by Products, 2012 – 2020 (USD Million)
New Zealand Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
New Zealand Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
New Zealand Insulin Market, by Product Types, 2012 - 2020 ('000 units)
New Zealand Insulin Market, by Source Types, 2012 - 2020 (USD million)
New Zealand Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
New Zealand Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Indonesia Insulin Market, by Products, 2012 – 2020 (USD Million)
Indonesia Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Indonesia Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Indonesia Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Indonesia Insulin Market, by Source Types, 2012 - 2020 (USD million)
Indonesia Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Indonesia Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Philippines Insulin Market, by Products, 2012 – 2020 (USD Million)
Philippines Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Philippines Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Philippines Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Philippines Insulin Market, by Source Types, 2012 - 2020 (USD million)
Philippines Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Philippines Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
Taiwan Insulin Market, by Products, 2012 – 2020 (USD Million)
Taiwan Insulin Prices, by Product Type, 2012 - 2020 (USD/Unit)
Taiwan Insulin Prices in Private Sector, by Product Types, 2012 – 2020 (USD/Unit)
Taiwan Insulin Market, by Product Types, 2012 - 2020 ('000 units)
Taiwan Insulin Market, by Source Types, 2012 - 2020 (USD million)
Taiwan Insulin Market, by Source Types, 2012 - 2020 (‘000 Units)
Taiwan Insulin Market, by Diabetes Types, 2012 - 2020 (USD Million)
LIST OF FIGURES
Asia Pacific Insulin Market Segmentation
Asia Pacific Insulin Market Revenue, 2012 - 2020
Asia Pacific Insulin Market Dynamics
Asia Pacific Insulin Company Market Share Analysis, 2012
Key Opportunities Prioritized
Industry Analysis - Porter's
Asia Pacific Insulin PESTEL Analysis, 2012
Asia Pacific Insulin market - company market share analysis, 2013 (%)
Asia Pacific insulin market, by product type, 2012 – 2020
Asia Pacific insulin market, by source types, 2012 – 2020
Asia Pacific insulin market, by applications, 2012 – 2020
Asia Pacific Insulin Market Segmentation
Asia Pacific Insulin Market Revenue, 2012 - 2020
Asia Pacific Insulin Market Dynamics
Asia Pacific Insulin Company Market Share Analysis, 2012
Key Opportunities Prioritized
Industry Analysis - Porter's
Asia Pacific Insulin PESTEL Analysis, 2012
Asia Pacific Insulin market - company market share analysis, 2013 (%)
Asia Pacific insulin market, by product type, 2012 – 2020
Asia Pacific insulin market, by source types, 2012 – 2020
Asia Pacific insulin market, by applications, 2012 – 2020
